A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas

被引:42
|
作者
Laws, Edward R., Jr. [1 ]
Iuliano, Sherry L. [1 ]
Cote, David J. [1 ]
Woodmansee, Whitney [2 ]
Hsu, Liangge [3 ]
Cho, Charles H. [3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Div Endocrionol Diabet & Hypertens, Boston, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Div Neuroradiol, Boston, MA USA
关键词
Endoscopic transsphenoidal surgery; Macroadenoma; Pituitary function; Pituitary surgery; DELAYED HYPONATREMIA; ENDOCRINE FUNCTION; ADENOMAS; ENDONASAL; RECOVERY; COMPLICATIONS; RESECTION; HYPOPITUITARISM; PREDICTORS; PRESSURE;
D O I
10.1016/j.wneu.2016.04.059
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: We report a contemporary consecutive series of 80 patients operated on for benign pituitary macroadenomas, followed endocrinologically for at least 3 months postoperatively. These patients were systematically evaluated preoperatively by high-resolution magnetic resonance imaging designed to detect the position of normal gland relative to the lesion. The rate of preservation of normal pituitary was critically analyzed using this strategy combined with endoscopic transsphenoidal resection. METHODS: This is a retrospective review of 46 women and 34 men with mean postoperative follow-up of 14 months (range, 3-30 months). The lesions encountered consisted of 80 pituitary macroadenomas (55 nonfunctioning, 18 acromegaly, 5 prolactinoma, 1 Cushing, one thyroid-stimulating hormone). Pituitary endocrine status was determined preoperatively and at most recent follow-up, and categorized as normal or impaired, based on laboratory studies showing new hormone deficiency or the need for pituitary hormone replacement therapy. RESULTS: Fifty-three patients (66.3%) had normal endocrine function preoperatively; 3 (5.7%) had loss of function postoperatively (1 transient). Twenty-seven patients (33.8%) had impaired function preoperatively; postoperatively 20 (74.1%) were unchanged, and 5 (18.5%) were worse; 2 (7.4%) recovered lost pituitary function. Of 80 patients undergoing resection, 5 (6.3%) had worsened pituitary function postoperatively. Patients with recurrent lesions (n = 5, 6.3%) and those presenting with pituitary tumor apoplexy (n = 5, 6.3%) were more likely to become further impaired. Other endocrine sequelae included 2 patients with permanent postoperative diabetes insipidus and 3 with transient symptomatic syndrome of inappropriate secretion of antidiuretic hormone. CONCLUSIONS: The preservation and restoration of hormonal function are essential to assessing the outcome of surgery and to the patient's quality of life. Careful analysis of the anatomy of the pituitary lesions and their effect on the anatomy and physiology of the pituitary gland are crucial to success and allow modern technological advances to provide fewer complications of therapy and improved outcomes for our patients. The benchmarks provided in this article are a stimulus for even better results in the future as we take advantage of technical and conceptual advances and the benefits of multidisciplinary collaboration.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [21] The complications of endoscopic transsphenoidal surgery for pituitary neoplasms
    Zhong, Ailing
    Pu, Jiujun
    Ruan, Lunliang
    Jin, Kai
    Tan, Song
    Wang, Fuchao
    Mou, Jiamin
    Yang, Gang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20026 - 20031
  • [22] Endoscopic endonasal transsphenoidal surgery for pituitary adenomas
    Saeki, Naokatsu
    Murai, Hisayuki
    Hasegawa, Yuzo
    Horiguchi, Kentaro
    NEUROLOGICAL SURGERY, 2007, 35 (10): : 971 - 985
  • [23] Endoscopic endonasal transsphenoidal surgery for pituitary macroadenoma
    Sankhla, SK
    Minimally Invasive Neurosurgery and Multidisciplinary Neurotraumatology, 2006, : 195 - 201
  • [24] Endoscopic transseptal transsphenoidal surgery for pituitary tumors
    Yaniv, E
    Rappaport, ZH
    NEUROSURGERY, 1997, 40 (05) : 944 - 946
  • [25] EXPERIENCE OF ENDOSCOPIC TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA
    Guo, X.
    Piao, H.
    Yao, B.
    Sun, P.
    Zhang, Y.
    Sui, R.
    Chen, Y.
    Shi, J.
    Liang, H.
    NEURO-ONCOLOGY, 2016, 18 : 79 - 79
  • [26] Perioperative management of endoscopic transsphenoidal pituitary surgery
    Hanson Martin
    Li Hao
    Geer Eliza
    Karimi Sasan
    Tabar Viviane
    Cohen Marc A.
    Multidisciplinary Pituitary and Skull Base Tumour Program
    世界耳鼻咽喉头颈外科杂志英文版, 2020, (02) : 84 - 93
  • [27] Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas
    Pinar, Ercan
    Yuceer, Nurullah
    Imre, Abdulkadir
    Guvenc, Gonul
    Gundogan, Onur
    JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (01) : 205 - 209
  • [28] The Impact of Extended Procedure Duration on Nasal Morbidity after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Macroadenomas
    Carey, Preston
    Kelly, Patrick D.
    Vinjamuri, Shreya
    Smit, Rupert
    Doshi, Riyana
    Shah, Riya
    Murayi, Roger
    Farquhar, Douglas
    Rabinowitz, Mindy R.
    Nyquist, Gurston G.
    Rosen, Marc R.
    Bray, David
    Evans, James J.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2025,
  • [29] Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma
    Tomita, Yusuke
    Kurozumi, Kazuhiko
    Inagaki, Kenichi
    Kameda, Masahiro
    Ishida, Joji
    Yasuhara, Takao
    Ichikawa, Tomotsugu
    Sonoda, Tomoko
    Otsuka, Fumio
    Date, Isao
    ACTA NEUROCHIRURGICA, 2019, 161 (04) : 707 - 715
  • [30] Operative Learning Curve After Transition to Endoscopic Transsphenoidal Pituitary Surgery
    Shikary, Tasneem
    Andaluz, Norberto
    Meinzen-Derr, Jareen
    Edwards, Collin
    Theodosopoulos, Philip
    Zimmer, Lee A.
    WORLD NEUROSURGERY, 2017, 102 : 608 - 612